<- Go Home
Forward Pharma A/S
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Market Cap
$7.4M
Volume
358.00
Cash and Equivalents
$65.3M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$882.86
52 Week Low
$200.00
Dividend
N/A
Price / Book Value
0.12
Price / Earnings
-11.83
Price / Tangible Book Value
0.12
Enterprise Value
-$54.9M
Enterprise Value / EBITDA
N/A
Operating Income
-$3.9M
Return on Equity
0.83%
Return on Assets
-3.42
Cash and Short Term Investments
$65.3M
Debt
$2.9M
Equity
$62.1M
Revenue
N/A
Unlevered FCF
-$2.2M
Sector
Biotechnology
Category
N/A